Optical coherent tomography in the diagnosis of inflammatory and ischemic optical neuropathies (clinical cases)

Authors

DOI:

https://doi.org/10.15587/2519-4798.2021.237821

Keywords:

optic nerve, neuropathy, OCT, perimetry, scotoma, inflammatory neuropathy, ischemic neuropathy, glaucoma neuropathy, nerve fibres, friends

Abstract

Optic neuropathy is a group of diseases of the optic nerve. Using diagnostic techniques such as ophthalmoscopy and perimetry diagnosis are insufficient, as the found abnormalities are not specific for either inflammation or ischemia. Establishing the predominant factor in the pathogenesis of neuropathy is crucial in determining the method of treatment.

The aim of the study: to investigate the features of optic nerve damage using optical coherent tomography (OCT) in optic neuropathy in the acute period.

Materials and methods: two patients with visual impairment were examined.

Result. Patient G. had concomitant rheumatoid arthritis with unregulated Methotrexate therapy. OCT revealed edema of the nerve fibre layer convinced of the predominance of inflammatory neuropathy (atypical neuritis). Pulse therapy with corticosteroids was prescribed, which gave a positive functional effect.

A patient O. with pneumonia on the background of Covid-19 with a history of OST showed a decrease in the thickness of the layer of nerve fibres in the lower segment, and in the angio mode – drusen of the optic disc.

Conclusions. Thus, the use of OCT for the diagnosis of optic neuropathies in the acute period showed that under conditions of inflammatory lesions is more characteristic of edema and an increase in the thickness of the layer of nerve fibres. In ischemic neuropathy, on the contrary, a decrease in the thickness of nerve fibres is more characteristic, which correlates in location with the localization of scotoma in the field of view.

Therefore, the use of OCT of the optic nerve will help in understanding the pathogenesis of forms of optic neuropathy. This will help in the choice of treatment tactics

Author Biography

Nataliya Moyseyenko, Ivano-Frankivsk National Medical University

Doctor of Medical Sciences, Associative Professor

Department Ophthalmology

References

  1. Costello, F. (2014). Inflammatory Optic Neuropathies. CONTINUUM: Lifelong Learning in Neurology, 20, 816–837. doi: http://doi.org/10.1212/01.con.0000453316.60013.52
  2. Yassa E.T., Bakbak B. (2019) Chronic Relapsing Inflammatory Optic Neuropathy. The Medical Bulletin of Sisli Hospital, 53 (4), 437–440. doi: http://doi.org/10.14744/semb.2017.58561
  3. Wen, Y.-T., Huang, C.-W., Liu, C.-P., Chen, C.-H., Tu, C.-M., Hwang, C.-S. et. al. (2021). Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions. Investigative Opthalmology & Visual Science, 62 (6), 21. doi: http://doi.org/10.1167/iovs.62.6.21
  4. Moyseyenko, N. M. (2019). The pathogenic aspects of traumatic optical neuropathy’s neuroprotec-tive therapy. Art of Medicine, 4 (12), 84–91. doi: http://doi.org/10.21802/artm.2019.4.12.84.
  5. Sharma, R., Sharma, P. (2011). Toxic optic neuropathy. Indian Journal of Ophthalmology, 59 (2), 137–141. doi: http://doi.org/10.4103/0301-4738.77035
  6. Chan, Jane W. (2014) Optic Nerve Disorders Diagnosis and Management. Springer is part of Springer Science: Business Media, 376. doi: http://doi.org/10.1007/978-1-4614-0691-4
  7. Grzybowski, A., Barboni, P. (2020). OCT and Imaging in Central Nervous System Diseases. The Eye as a Window to the Brain. Springer International Publishing AG Switzerland is part of Springer Science: Business Media, 343. doi: http://doi.org/10.1007/978-3-030-26269-3
  8. Kidd, D. P. (2008). Chapter 7 Inflammatory Optic Neuropathies Not Associated with Multiple Sclerosis. Blue Books of Neurology, 32, 153–190. doi: http://doi.org/10.1016/s1877-184x(09)70037-1
  9. Clare, G., Colley, S., Kennett, R., Elston, J. S. (2005). Reversible Optic Neuropathy Associated With Low-Dose Methotrexate Therapy. Journal of Neuro-Ophthalmology, 25 (2), 109–112. doi: http://doi.org/10.1097/01.wno.0000166061.73483.ce
  10. Sbeity, Z. H, Baydoun, L., Schmidt S., Loeffler K. U. (2006) Visual field changes in methotrexate therapy. Case report and review of the literature. J. Med. Liban., 54 (3), 164–167.
  11. Han, S., Jung, J. J., Kim, U. S. (2015). Differences between Non-arteritic Anterior Ischemic Optic Neuropathy and Open Angle Glaucoma with Altitudinal Visual Field Defect. Korean Journal of Ophthalmology, 29 (6), 418–423. doi: http://doi.org/10.3341/kjo.2015.29.6.418
  12. Fard, M. A., Ghahvehchian, H., Subramanian, P. S. (2020). Optical coherence tomography in ischemic optic neuropathy. Annals of Eye Science, 5, 6–6. doi: http://doi.org/10.21037/aes.2019.12.05
  13. Fraser, J. A., Rueløkke, L. L., Malmqvist, L., Hamann, S. (2020). Prevalence of Optic Disc Drusen in Young Patients With Nonarteritic Anterior Ischemic Optic Neuropathy: A 10-Year Retrospective Study. Journal of Neuro-Ophthalmology, 41 (2), 200–205. doi: http://doi.org/10.1097/wno.0000000000000974
  14. Sanfilippo, F., La Rosa, V., Oliveri, F., Astuto, M. (2021). COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma. American Journal of Respiratory and Critical Care Medicine, 203 (2), 257–258. doi: http://doi.org/10.1164/rccm.202008-3139le
  15. Yang, J. M., Park, S. W., Ji, Y. S., Kim, J., Yoo, C., Heo, H. (2017). Postural effects on intraocular pressure and ocular perfusion pressure in patients with non-arteritic anterior ischemic optic neuropathy. BMC Ophthalmology, 17 (1). doi: http://doi.org/10.1186/s12886-017-0441-3

Downloads

Published

2021-07-30

How to Cite

Moyseyenko, N. (2021). Optical coherent tomography in the diagnosis of inflammatory and ischemic optical neuropathies (clinical cases). ScienceRise: Medical Science, (4(43), 35–40. https://doi.org/10.15587/2519-4798.2021.237821

Issue

No. 4(43) (2021)

Section

Medical Science

License

Copyright (c) 2021 Nataliya Moyseyenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.